{"id":"https://openalex.org/W2383080276","doi":null,"title":"Investigation of the effect of combined matrine and chemotherapeutic agents on P-gp of KBV200 cell line","display_name":"Investigation of the effect of combined matrine and chemotherapeutic agents on P-gp of KBV200 cell line","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2383080276","mag":"2383080276"},"language":"en","primary_location":{"id":"mag:2383080276","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-CQYX200614015.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764819181","display_name":"Chongqing yixue","issn_l":"1671-8348","issn":["1671-8348"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4320800525","host_organization_name":"Chinese Medical Association","host_organization_lineage":["https://openalex.org/P4320800525"],"host_organization_lineage_names":["Chinese Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chongqing yixue","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Yan Shu","orcid":"https://orcid.org/0000-0001-8492-1437","observed_orcids":["https://orcid.org/0000-0001-8492-1437"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Yan Shu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8492-1437","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.30616074,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/matrine","display_name":"matrine","score":1.0},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9459999799728394},{"id":"https://openalex.org/keywords/multidrug-resistance-reversal","display_name":"multidrug resistance reversal","score":0.8840000033378601},{"id":"https://openalex.org/keywords/kbv200-cells","display_name":"KBv200 cells","score":0.9039999842643738},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.9259999990463257},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6819999814033508},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.36899998784065247},{"id":"https://openalex.org/keywords/multidrug-resistance-associated-protein","display_name":"multidrug resistance-associated protein","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C2776545273","wikidata":"https://www.wikidata.org/wiki/Q6787831","display_name":"Matrine","level":2,"score":0.9426639080047607},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.8461563587188721},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.6295530796051025},{"id":"https://openalex.org/C2776232574","wikidata":"https://www.wikidata.org/wiki/Q415571","display_name":"Bleomycin","level":3,"score":0.6266140937805176},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.5969935655593872},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5529893040657043},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5439337491989136},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.45376574993133545},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3854103684425354},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.326901912689209},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3260553479194641},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.19590350985527039},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1426135003566742},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1293540596961975},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09130966663360596},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.06693127751350403},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.05178004503250122},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2383080276","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-CQYX200614015.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764819181","display_name":"Chongqing yixue","issn_l":"1671-8348","issn":["1671-8348"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4320800525","host_organization_name":"Chinese Medical Association","host_organization_lineage":["https://openalex.org/P4320800525"],"host_organization_lineage_names":["Chinese Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chongqing yixue","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2387606568","https://openalex.org/W2383083385","https://openalex.org/W2365369421","https://openalex.org/W2382999016","https://openalex.org/W2146790338","https://openalex.org/W1974273785","https://openalex.org/W2363987651","https://openalex.org/W2347426302","https://openalex.org/W2954587962","https://openalex.org/W3028866586"],"abstract_inverted_index":{"Objective":[0],"To":[1],"observe":[2],"the":[3,15,29,34,50,55,69,74],"effect":[4,35],"of":[5,17,19,31,38,57,71,73],"matrine":[6],"in":[7,42,60],"combination":[8,43,61],"with":[9,44,62],"6":[10],"chemotherapeutic":[11],"agents":[12],"vincristine,adriamycin,bleomycin,cyclophospharmide,5-Fu,cisplatin":[13],"on":[14,36],"expression":[16,30,37,56,70],"P-glycoprotein(P-gp)":[18],"KBV200":[20,39,75],"cell":[21,76],"line.Methods":[22],"Flowcytometer(FCM)":[23],"assay":[24],"was":[25],"used":[26],"to":[27],"investigate":[28],"P-gp":[32,72],"and":[33,46,64],"cell.Results":[40],"Matrine":[41,59],"vincristine(VCR)":[45],"adriamycin":[47,65],"can":[48,66],"reverse":[49],"multidrug":[51],"resistance(MDR)":[52],"by":[53],"decreasing":[54],"P-gp.Conclusion":[58],"vincristine":[63],"cut":[67],"down":[68],"line.":[77]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}